FAST: Functional Analysis & Screening Technologies Congress
October 28-30, 2013
With the tremendous expense of bringing new drugs to market, a focus on improving the outcome of first-stage research is critical. Recent evidence confirms the need for innovative screening systems utilizing assay design on three-dimensional tissue models and phenotypic models. This functional analysis will allow for more accurate biological response. Cambridge Healthtech Institute is pleased to introduce FAST: Functional Analysis & Screening Technologies Congress to bring together drug research and development teams for practical discussion, solutions and case studies for refining these first-stage drug discovery methods.
Engineering Functional 3-D Tissue Models
Phenotypic Drug Discovery
Screening and Functional Analysis of 3-D Models
Physiologically-Relevant Cellular Tumor Models for Drug Discovery